Cargando…

Antihypertensives: sex differences in risk of COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417669/
http://dx.doi.org/10.1007/s40278-021-01526-7
_version_ 1783748426362519552
collection PubMed
description
format Online
Article
Text
id pubmed-8417669
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84176692021-09-07 Antihypertensives: sex differences in risk of COVID-19 Reactions Weekly Clinical Study Springer International Publishing 2021-09-04 2021 /pmc/articles/PMC8417669/ http://dx.doi.org/10.1007/s40278-021-01526-7 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Antihypertensives: sex differences in risk of COVID-19
title Antihypertensives: sex differences in risk of COVID-19
title_full Antihypertensives: sex differences in risk of COVID-19
title_fullStr Antihypertensives: sex differences in risk of COVID-19
title_full_unstemmed Antihypertensives: sex differences in risk of COVID-19
title_short Antihypertensives: sex differences in risk of COVID-19
title_sort antihypertensives: sex differences in risk of covid-19
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417669/
http://dx.doi.org/10.1007/s40278-021-01526-7